st. john's st. john's health - nuclear regulatory commission · st. john's...
TRANSCRIPT
ST. JOHN'S
04/16/2006
Materials Licensing US NRC Region 111 2443 Warrenville Roacl Suite 2 1 Lisle, IL 60532-4352
ATTN License reviewer:
ST. JOHN'S HEALTH SYSTEM
417-820-2000 ph 1235 EAST CHEROKEE STREET SPRINGFIELD, MISSOURI 65804-2263
This letter is a request to add Dr Henry G. Stratmann, MD as an authorized user under 35.200 limited to cardiovascular clinical procedures to our NRC materials license number 24-00866-02.
You will find enclosed copies of Dr. Stratmann's Board certifications in Nuclear Cardiology from 1997-2007 and from 2007-2017 as well as preceptor statements from Dr Fletcher for clinical experience obtained in 1995-1996 and from Dr Myears in 2002- 2005. I have also included numerous certificates for continued medical education from 1997-2005 and a list of Nuclear Cardiology publications for Dr Stratmann.
If you have any questions regarding this request or if you require additional information please contact me at 4 17-820-7704.
Sincerely,
Nick Lannutti, MS Radiation Safety Officer Department of Nuclear Medicine St Johns Hospital-Springfield
Enclosure: 2 Board Certification certificates Preceptor statements from Dr Fletcher and Dr. Myears CME documentation List of Nuclear Cardiology publications
Cc Michael Barnes, Nuclear Medicine Henry Stratmann, MD Linda Earnest, Administration
A member of the Sisle,s cf Mercy %al:P $Y51em A Top 20 Health System
HAVING MET THE REQUIREMENTS PRESCRIBED BY THIS COUNC~L AND HAVING SATISFACTORILY PASSED THE REQWlRED EXAMINATION,
IS HEREBY DESIGNATED
A DIPLOMATE CERTIFIED IN THE SUBSPECIALTY OF
NUCLEAR CARDIOLOGY FOR THE PERIOD 1997 THROUGH 2007
. ?
--__---- -------- PRESIDCNI.
L
CERIIPICATI: # DECEMBER I , 1997
‘Henry G. Strabnann, MD HAYING MET THE RECERTIFKATION REQUIREMENTS PRESCRIBED BY THIS BOARD
FOR PHYSICIANS TRAZNED IN THE UNITED STATES AND HAVING SATISFACTORILY PASSED THE REQUIRED EXAMINATION,
IS HEREBY DESIGNATED A DIPLOMATE CERTIFIED IN THE SUBSPECIALm OF
NUCLEAR CARDIOLOGY FOR THE PERIOD 2007 * 2017
b.2 m h C @i$ Secretary
CERTIFICATE NUMBER: 844
DEPARTMENT OF VETERANS AFFAIRS Medical Center
St Louis MO 63125
In Reply Re'erTo 657/115/JC
*May 21,1996
To Whom I t May Concern:
This letter is to affirm that Henry C. Stratmann, M.D., has gained clinical experience at our institution in nuclear rardinlogy. The preceptorship began September 1,1995 and continued through April 1, 1996. During this period, the doctor actively participated in the following number of procedures:
a 3 Cardiac Perfusion Scan 2 Cardiac Rest Ventriculogram
During this time, Dr. Stratmann also acquired experience in health physics, radiopharmaceutical preparation, technical and administrative procedures of our facility, as well as, general operation as stipulated by our license conditions.
The doctor gained experience in the preparation of radiopharmaceutical kits during this period, and eluted the WmTc/99Mo generator.
nuclear cardiology clinical and work experience during this period total 520 hours.
Facility Nuclear Regulatory Commission (NRC) License NOS.
SLU: 24-001 96-07 VA - 23-00144-05
- . .-
IT------------
I I S t . L o u i s U n i v e r s i t v I I V A P
I
I
! Tagged
I r c ' 7
-1
I I I
__L_-
. .
I
j RBC labe 1 leg Tc9grn j tagged RBCs in vitro
, 2 i
~~~~~ ~~~~~~~~~ ~~
NRC: FGZW ?1?A r . 2 j j g :
U.3 . t4YCLEAR REGULATORY COMMISSION
A???31'E3 8 Y OM3: NO. 3155-012 EXPl2ES: 10:31'20':5 MEDICAL USE TRAlNlNG AND EXPERIENCE
AND PRECEPTOR ATTESTATION PART I - -TWINING AND EXPERIENCE
4. iNDlVlDLlALS IDENTIFIED ON A LICENSE 0 2 ?ERMiT AS ZADIATIDN SAFETY OFFiCERS (ZSO), AUTktOilIZED USERS (AU), AUTHOZIZED MEDICAL PHYSICISTS (.AM?), 03
AUTHOXlZfD NUCLEAR P%-:AZMAC!STS (AN?) SEEKING ADDITIONAL AUTHO?IZATICNS !. ?iOvids a copy of ih? license or Srcadsc3pa pe:rnit lkting the currmt auihoriztion and (b) or (C,
1 Co;n?ier~ it9rr.j 6c (and 10 whin traini7l; IS pi3\/idsm3 by an %SO, AM?, AN?, oi AUj an3 piaci3ior items i 15 :iircJug+ 11 d 13 mezt raquirsmsnts for: ?SO in 35.50(~)(2) or 35.50(e): or ,AIJ 13 35 230(c)ji)iii)(G) or 35.33l?i'Sj(i )(ii)(G) o i 35 590(c) or 35.630(c); or AM? unds: 35.51 (cj.
Conpk?s ;terns 5, Sa, 6b, 10, an3 ?:?csptor itszs 1 <a through 1 I d to meet AU rquir?mzn:s in 35.335(2)
5 . DIDACTIC OX CLASSZOOM AND LS3OiATOXY TRAIN!NG (optional for Midical physicists)
Diszri$ion of Training Location Clack Hogrs Catas of Training
Iad,aiion 2nyslcs an6 ?SkJ iTl?nkItlO;l
?3diailGri Protiction
dair~imatrcs ,?eriaininG io the Uss nd Measclrernent o i Zarjioactivitj,
4SC FO?M 312A U S YUCLEAi? REGULATORY COb'JldlSSIC L 2 x 5
MEDICAL USE TRAINING AND EXPE2IENCE AND ?i?ECE?TOR ATTESTATION (continuec' j
6.. VIIOXK OX ?XACTICAL EXPERIENCE WITH RADIATION
Discription o f Expirience
Location and Dates an-d!c Corresponding Clack
Materials L ic inse Hours of Number txperiensc
Name of Supexising Individusl(s) -
3ares andio
Hours of
Location and
Materials Li cen ss Corresponding Clock Name of
Supirdsing Individual Number ExDeriince
~
43C FORM 3 i ? A U S NUCLEAR ?:EGUL4TO?Y COf4hl!SSIO'i L-23: 5,
MEDICAL U S E TiiAlNlNG AND EXPERIENCE AND ?ZECE?TOX ATTESTATiON (continzed)
6c. TRAINING FOX SECTIONS 35.50(e) , 35.51(c), 35 59D(c), G: 35.630(c)
I :aining Ele;nent Type of Train;ng Location a n d Dates -
t h s RSO for License No
3. MEDICAL WYSICIST -- oNE-YEaR FULL-TIME TFIAININWWORK EX?ERIENCE
and
V2C FOZM 313A L.?:35,
MEDICAL USE TiiAlNLNG AND EXPERIENCE AND ?XlECE?TOR ATTESTATION (continu.di
American Society of Nuclear Cardiology 91 11 Old Georgetown Road Bethesda, Maryland 20814-1699
(301) 493-2360 FAX (301) 493-2376
ASNC 1 American Society of Nuclear Cardiology
This Statement is for Enrollee's Records
attended a continuing medical education program entitled "2nd ASNC TUTORIAL IN NUCLEAR CARDIOLOGY"
from SEPTEMBER 12-14, 1997 in BOSTON, MA. The American Society of Nuclear Cardiology is accredited by the Accreditation
Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The American Society of Nuclear Cardiology designates this continuing medical education activity for 18.0 hours in Category 1 of
the Physician's Recognition Award of the American Medical Association.
Chairman, ASNC Continuing Medical Education Committee
C M E
! R E D I ~ S T A T E M E N T
TOP COPY OF STATEMENT REQUIRES VALIDATION AND IS FOR REGISTRANT RECORDS
THE AMERICAN COLLEGE OF CARDIOLOGY is accredited by the Accreditation Council for Continuing Medical
Registration Number-Required
48th Annual Scientific Session, March 7-1 0, 1999, in New Orleans, Louisiana.
The American College of Cardiology designates this educational activity for up to 39.0 hours in category 1 credit towards the AMA Physician‘s Recognition Award. Each physician should
claim only those hours of credit that he/she actually spent in the educational activity.
Sue Sears Hornllton, Director Annual Scientific Scsskn & Meeting Services
Sunday Up to 12.0 ha.
Monday Tuesday Wednesday Up to 9.0 hrs. Up to 10.5 hrs. Up to 7.5 hrr. - ACC’99 - -I- may be claimed -P may be ~ claimed -t m a y ~ c l a i r n e d G r z d y
Indicate hours claimed and return bottom copy to the CME Validation Counter a t any Portfolio Pick-Up Station, completing the evaluation on reverse side. This is your official record of attendance. Please save for your records. We recommend that you save the entire
Final frogworn for your records should information be requested from you. Reporting is done on an honor basis.
(Max. 39 0 hn.) 9
TOP COPY OF STATEMENT REQUIRES VALIDATION AND IS FOR REGISTRANT RECORDS
THE AMERICAN COLLEGE OF CARDIOLOGY is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
attended the 49th Annual Scientific Session, March 12-1 5, 2000, in Anaheim, California.
The American College of Cardiology designates this educational activity for up to 36.0 hours in category 1 credit towards the AMA Physician’s Recognition Award. Each physician should
claim only those hours of credit that he/she actually spent in the educational activity.
Sue Sears Hamilton, Director Annual Scientific Session & Meeting Services
Mondmv Tuadml -1- *a& 14. moo IW.rdt15 2wo __ -_ - - __ - - - NcCh12.20oo Marsh13 2000
I_ - -. - ___^ - .__ -
Sunday Monday Tuesday Wednesday ACCZOOO
CrandTotal
(Max 35 0 hrs)
Up to 11 5 hrs + Up to 9.5 hrs Up to 10.0 hrs Up to 5 0 hrs - 4- may be 4 lairned -I- may be lamed - may b;zimed may be T m e d
- .JAL Indicate hours claimed and return bottom copy to the CME Validation Counter at any Portfolio Pick-Up Station, completing the
evaluation on reverse side This i s your official record of attendance. Please save for your records We recommend that you save the entire FtnaJ Program for your records should information be requested from you. Reporting is done on an honor basis
i
T h e American College of Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American College of Car- diology takes responsibility for the content, quality, and scien- tific integrity of this CME ac- tivity.
This CME activity was planned and produced in accordance with the ACCME essentials.
AMERICAN COLLEGE of
CARDIOLOGY
91 1 1 Old Georgetown Road Bethesda, Maryland 20814-1699 301-897-5400 800-253-4636 www.acc.org
ACCSAP 2000 Adult Clinical Cardiology SelfcAssessment Program Fourth Edition-Issued June 1999
Henry G. Stratmann, M.D.
CREDIT HOURS
The American College of Cardiology designates this educational
activity for a maximum of 115 hours in category 1 credit
towards the AMA Physician’s. Recognition Award. Each
physician should claim only those hours of credit that he/she
* .
actually spent in the educational activity.
Record actual hours here : 11 2 . o o
Anne Marie Smith Director, Educational Products
American College of Cardiology
The American College of Cardiology is accredted by the Accre&tation Council for Continuing Medcal Education to provide continuing medml education for physicians. The American College of Cardology takes responsibdm - tor the content, quahty, and scient& integrityLof t h s CME activity.
'
has participated in the educational activitt. entitled "THE ACC CARDIOVASCULAR BOARD REVIEW: CERTIFICATION AND RECERTIFICATION" at Chcago, IL on 9/7/2001 - 9/12/2001. The activity was designated for 58.5 hours toward the AMA Physician's Recopt ion Award category 1 credt. Each participant should claim only those hours of cre&t that he/she actually spent in the educational activity.
z---
*\T CERTIFICATE OF ATTENDANCE /
WORKING GROUP
VihswnUniversity in StLouis SCHOOL OF MEDICINE Carnpir b?. 8363
662 South Euclid Ave
3 14-~6?-6831 or RLW-3:5-%2
cnwZZm\nom uurtl edu htcp /,'cme u u t l lzfu
St LOUIS, 310 631 10-1093
FAX. 314-362-1CY7
HENRY G. STRATMANN, M.D. 4903 SOUTHRIDGE PARK ST LOUIS MO 63129
Washqton University IS accredited by the Accreditauon Council for Continuing h4edlcal Eilucation to probide iontinumg medical educaoon for physicians. Each physician should claim only those hours of credit that he/she actually spent in the cducarional activiy.
$ 2
American College of Cardiology Foundation
Continuing Medical Education Certificate for Enduring Materials
Category 1 Credit
continuing medical edu Cardiology Foundation scientific integrity of this CM and produced in accordance
Henry Stratmann, M.D.
Record actual hours: 150.00
Date Certificate Issued: May 1, 2003 Date ACCSAP I’Issued: March 2002 Term of Approval: March 2005
Exams - Certificate of Cornplerion 05/04/2005 10:43 AM
Search SNM Webste I , kdvanced Search >> ~
May 4, 2005
Dr. Henry Stratmann 471 1 S. Sedgewick Terrace Ct Springfekf, MO 65810-2430
AMNPRA (CME)
Exam Title
ID: 25791 7 Program Code: JNM2005
The Society of Nuclear Medicine confirms that you have successfully completed the exam listed betow.
Credits Date Passed Reference No. JNM/Myomdial Btood Flow Measurement by PET: Technical 5/4/2005 A020749 1.50 Aspects and Clinical Applications
AMAPRA (CME) Total: 1.50
Accreditation Statement for this Program AMCVPRA The Society of Nuclear Medicine is
I ' accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical , education for physicians. I
N. Lynn Barnes, MEd Director of Education
If you have any questions Department: Education regarding this certificate, please Society of Nuclear Medicine contact the SNM Education 1850 Samuel Morse Dr. Department Reston, VA 20190-5316
Phone: (703) 708-9000, ext. 1247
..I_.._-.--__._.._....___.. _..___.___I._....._._......__ ~ .... - ~ ~ .....
https://interactive.snm.org/index.cfm?PagelD=l664&RPlD=l265 Page 1 of 1
Exams - Cerrlf lcate o f Complet ion 05/04/2005 10 22 AM
Search SNM Webstte
Advanced Search >> /
May 4, 2005
Dr. Henry Stratmann 471 1 S. Sedgewick Telrace Ct. Springfield, h40 65810-2430
AMAIPRA (CME)
Exam Title The Additive Vafue of Combined Assessment of Myocardial Perfusion and Ventricular Function Studies
Acwedifafion SMfimerif for this Program A M W R A The Society of Nuclear Medicine is
accredited by the Acaeditation Council for Continuing M e d i c a f Education (ACCME) to sponsor continuing medical education for physicians.
__._._~..._.__.__.__I~..__I_._____.-._._~...... I _.-...
ID: 257917 Program Code: JNM2004
The Sodefy of Nudear Medicine confirms that you have successfully completed the exam listed befow.
Date Passed Reference No. credits 5/4/2005 A020663 1.00
AMAlPRA (CME) Total: 1.00
N. Lynn Barnes, MEd Director of Education
i f you have any questions Department. Education regarding this certificate, please Society of Nuclear Medicine contact the SNM Educatton 1850 Samuel Morse Dr. Department Reston, VA 20190-5316
Phone. (703) 708-9000, exl 1247
~ _ _ ._ - ._ I_I - - -- -
Faye 1 of 1
advancing molecular imaging
Society of Nuclear Medicine
Presented to
Henry G. Stratrnann, M.D.
This is to verify your participation in the education activity
Physician Evaluation Program (PEP) Myocardial Perfusion Imaging Module
on May 31,2005
The Society of Nuclear Medicine is accredited by the ACCME to sponsor continuing medical education for physicians.
The SNM designates this CME activity for a maximum of 30.0 hours of category 1 towards the AMA Physician Recognition Award. Each physician should claim only those hours of credit that helshe actually spent in the educational activity.
Participant is awarded 30.0 hours
N. Lynn Barnes, MEd Director of Education
I
!
American Society of Nuclear Cardiology 4550 Montgomery Ave., Suite 780 North Bethesda. Maryland 20814-3304
(301)215-7575 FAX (301) 215-7113 [email protected] www.asnc.org
I A S N C I This Statement is for Enrollee's Records
Henry G. Stratmann, MD completed a continuing medical education activity entitled
"Nuclear Cardiology Knowledge Self Assessment Program" on
Wednesday, October 4, 2006
The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to sponsor
continuing medical education for physicians.
The American Society of Nuclear Cardiology designates this educational activity for a maximum of 7 AMA PRA Category 7 Credit(s)TM.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Mylan C. Cohen. MD, MPH Chairman. ASNC Con ti nu ing Medical Education Corn mitt ee
American Society of Nuclear Cardiology
This Statement is for Enrollee’s Records
Henry Stratmann, MD attended a continuing medical education program entitled
“2006 Nuclear Cardiology Board Exam Preparation Course” held July 29-30 2006 in Chicago, IL. The American Society of
Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical
education for physicians.
The American Society of Nuclear Cardiology designates this educational activity for a maximum of 14.25 AMA PRA Category 7
the extent of their participation in the activity. Physicians should only claim credit commensurate with
Mylan C. Cohen, MD, MPH Chairman, ASNC Education Committee
pic s L I I Chdiology Publications (Abstracts and Articles)
Henry G. Stratmann, M.D.
Abstracts
1. Stratmann HG, Mark AL, Walter KE, Fletcher JW: Thallium-201 myocardial imaging and atrial pacing for diagnosis and physiologic assessment of coronary artery disease. Clinical Research 33(2):231 A, 1985.
2. Stratmann HG, Mark AL, Walter KE, Williams GA: Combined use of atrial pacing and thallium-201 myocardial imaging for diagnosis of coronary artery disease. Clinical Research 37(2):299A, 1989.
3. Stratmann HG, Mark AL, Walter KE, Williams GA: Correlation of atrial pacing and thallium-201 myocardial imaging with the extent of coronary artery disease. Clinical Research 37(2):299A, 1989.
4. Stratmann HG, Mark AL, Walter KE, Williams GA: Correlation of results of atrial pacing and thallium-201 myocardial imaging with coronary artery anatomy. Clinical Research 37(2):299A, 1989.
5. Stratmann HG, Mark AL, Walter KE, Williams GA: Preoperative evaluation of cardiac risk for vascular surgery using atrial pacing and thallium-201 imaging. Clinical Research 37(2):300A, 1989.
6. Stratmann HG, Mark AL, Walter KE, Williams GA: Prognostic value of atrial pacing and thallium-201 scintigraphy in patients with stable angina pectoris. Clinical Research 38(2) Presented at the National Meeting of the American Federation for Clinical Research, May 6, 1990.
7. Stratmann HG, Younis L: Prognostic value of dipyridamole-thallium-201 imaging in patients with stable angina pectoris. Clinical Research 40:405A, 1 992.
8. Takase B, Younis LT, Labovitz AJ, Stratmann H, Byers SL, Chaitman BR, Miller DD: Relative prognostic value of dipyridamole stress myocardial imaging and rest two-dimensional echocardiography in the preoperative stratification of elderly major nonvascular surgery patients. Presented at the XlVth European Society of Cardiology meeting, Barcelona, Spain, August, 1992.
Nuclear Cardiology Publication Henry G. Stratmann, M.D.
2
9. Younis LT, Takase B, Byers SL, Stratmann H, Chaitman BR, Miller DD: Enhancement of Goldman preoperative cardiac risk assessment with the use of intravenous dipyridamole thallium scintigraphy in patients referred for major nonvascular surgery. Presented at the XlVth European Society of Cardiology meeting, Barcelona, Spain, August, 1992.
10. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Goodgold HM, Chaitman BR, Miller DD: Prognostic value of diyridamole technetium-99m sestamibi myocardial imaging in > 300 consecutive patients with stable chest pain. Journal of the American College of Cardiology 21 :68A, 1993 Presented at the
42nd American College of Cardiology meeting, March, 1993.
11. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Wiens, RD, Chaitman BR, Miller DD: Dipyridamole sestamibi myocardial imaging for cardiac risk assessment before nonvascular surgery: Does every operation demand a preoperative stress study? Journal of the American College of Cardiology 21 :207A, 1993 Presented at the 42nd American College of Cardiology meeting, March, 1993.
12. Stratmann HG, Tamesis BR, Wittry MD, Younis LT, Wiens RD, Chaitman BR, Miller DD: Dipyridamole stress technetium-99m sestamibi myocardial tomography: An independent predictor of adverse outcome in patients following acute ischemic events. Journal of Nuclear Medicine, 34:85P, 1993. Presented at the Society of Nuclear Medicine meeting, June, 1993.
13. Stratmann HG, Williams GA, Wittry MD, Miller DD: Prognostic value of exercise testing with technetium-99m sestamibi in >500 patients with stable chest pain. Circulation (suppl) 88:l-486, 1993. Presented at the American Heart Association meeting, November 10, 1993.
14. Stratmann HG, Tamesis BR, Younis LT, Caralis DG, Wittry MD, Chaitman BR, Miller DD: Dipyridamole sestamibi tomography optimizes perioperative outcome and defines late prognosis in vascular surgery patients. Circulation (suppl) 88:l-440, 1993. Presented at the American Heart Association meeting, November 10,1993.
15. Stratmann HG, Tamesis BR, Wittry MD, Younis LT, Wiens RD, Chaitman BR, Miller DD: Dipyridamole sestamibi myocardial tomography: An independent predictor of adverse outcome in unstable angina patients. Circulation (suppl)
88:l-487, 1 993. Presented at the American Heart Association meeting, November 10, 1993.
Nuclear Cardiology Publication Henry G. Stratmann, M.D.
3
16. Stratmann HG, Younis LT, Wittry MD, Miller DD: Prognostic value of exercise testing with tt.~hr~tium-59m sestamibi in patients with medically treated unstable angina. Circulation (suppl) 90:l-102, 1994. Presented at the American Heart Association meeting, November, 1994.
17. Miller DD, Stratmann HG, Shaw LJ, McClellan JR, Heller GV: Gender and myocardial perfusion--Key cardiovascular outcome covariables in a multicenter study of stable angina patients undergoing stress Tc-99m sestamibi myocardial tomography. Circulation 92.1-129, 1995. Presented at the American Heart
Association meeting, November, 1995.
18. AI-Joundi TI Stratmann HG, Younis LT, Miller DD: Long-term prognostic utility of stress technetium-99m sestamibi myocardial perfusion tomography and coronary angiography in coronary artery bypass surgery patients. Journal of the American College of Cardiology 29:227A-228A, 1996. Presented at the American College of Cardiology meeting, March 1997.
19. Deedwania PC, Leppo JA, Stratmann HG, Kleiger RE, Blaustein A, Chow BW, Lavori PW, Boden WE: Can thallium imaging identify non-Q wave infarction patients at risk for cardiac events? Circulation 96:l-195, 1997.
20. Fayyaz I, Yokoyama Y, Osada N, Stratmann HG, Merkle B, Miller DD: The discriminant prognostic value of adding exercise myocardial SPECT Imaging to peak oxygen uptake (MV02) in congestive heart failure patients. Journal of the
American College of Cardiology 31 :198A, 1998. Presented at the American College of Cardiology meeting, March, 1998.
Articles
1. Stratmann HG, Seuc CAI Mark AL, Walter KE, lschinger T, Kennedy HL: Assessment of percutaneous transluminal coronary angioplasty by atrial pacing and thallium-201 myocardial imaging: A case report. Angiology 38:610-613,1986.
2. Stratmann HG, Mark AL, Walter KE, Fletcher JW, Williams GA: Atrial pacing and thallium-201 scintigraphy: Combined use for diagnosis of coronary artery disease. Angiology 38:807-814, 1987.
3. Stratmann HG, Mark AL, Walter KE, Williams GA: Diagnostic value of atrial pacing and thallium-201 scintigraphy for the assessment of patients with chest pain. Clinical Cardiology 12:193-201,1989.
Nuclear Cardiology Publication Henry G. Stratmann, M.D.
4
4. Stratmann HG, Mark AL, Walter KE, Williams GA: Atrial pacing and thallium-201 scintigraphy in patients with chest pain: Correlation with coronary anatomy. Clinical Cardiology1 2:185-192, 1989.
5. Stratmann HG, Mark AL, Walter KE, Williams GA: Preoperative evaluation of cardiac risk using atrial pacing and thallium-201 scintigraphy. Journal of Vascular Surgery 10:385-391 , 1989.
6. Stratmann HG, Mark AL, Walter KE, Williams GA: Prognostic value of atrial pacing and thallium-201 scintigraphy in patients with stable chest pain. American Journal of Cardiology 64:985-990,1989.
7. Stratmann HG, Mark AL, Walter KE, Williams GA: Thallium-201 perfusion imaging with atrial pacing or dipyridamole stress testing for evaluation of cardiac risk prior to nonvascular surgery. Clinical Cardiology 13:611-616, 1990.
8. Stratmann HG, Younis LT, Kong 6: Prognostic value of dipyridamole thallium-201 scintigraphy in patients with stable chest pain. American Heart Journal 123:317-323, 1992.
9. Stratmann HG, Flynn M, Littlefield JL, Wittry MD: Myocardial imaging with technetium-99m sestamibi and exercise-induced ventricular tachycardia. American Heart Journal 124:1374-1377, 1992.
10. Stratmann HG, Younis LT, Kong B: Thallium-201 scintigraphy in patients with stable chest pain. Cardiology Board Review 10:85-89, 1993.
11. Stratmann HG, Williams GA, Wittry D, Chaitman BR, Miller DD: Exercise technetium-99m sestamibi tomographic imaging for assessment of cardiac risk in patients presenting for evaluation of chest pain. Circulation 89:615-622, 1994.
12. Miller D, Stratmann H, Shaw L, Tamesis B, Wittry M, Younis L, Chaitman 6: Dipyridamole technetium-99m myocardial tomography as an independent predictor of cardiac-event free survival following acute ischemic events. Journal of Nuclear Cardiology 1 :72-82, 1994.
13. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD: Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. American Journal of Cardiology 73:647-652, 1994.
Nuclear Cardiology Publication Henry G. Stratmann, M.D.
14. Younis L, Stratmann H, Takase B, Byers S, Chaitman B, Miller D: Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease.
American Journal of Cardiology 74:311-317, 1994.
5
15. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Amato ME, Miller DD: Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina.
American Heart Journal 130:734-740, 1995.
16. Stratmann HG, Younis LT, Wittry MD, Amato ME, Miller DD: Prognostic value of exercise testing with technetium-99m sestamibi in patients with unstable angina. American Journal of Cardiology 76:236-240, 1 995.
17. Stratmann HG, Younis LT, Wittry MD, Amato ME, Miller DD: Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: Prognostic value for perioperative and late cardiac events. American Heart Journal 131 :923-929, 1996.
18. Stratmann HG, Younis LT, Wittry MD, Amato ME, Mark AL, Miller DD: Dipyridamole technetium-99m sestamibi myocardial tomography for preoperative cardiac risk stratification prior to major or minor nonvascular surgery. American Heart Journal 132536-541,1996.
19. Stratmann HG, Younis LT, Wittry MD, Mark AL, Amato ME, Miller DD: Sensitivity of exercise technetium-99m sestamibi tomography for identifying coronary artery disease: Relation to level of exertion achieved. Clinical Cardiology 19:787-792, 1996.
20. Miller DD, Younis LT, Chaitman BR, Stratmann HG: Diagnostic accuracy of dipyridamole technetium-99m sestamibi myocardial tomography for coronary artery disease detection. Journal of Nuclear Cardiology 4:18-24, 1997.
21. Alkeylani A, Miller DD, Shaw LJ, Travin MI, Stratmann HG, Jenkins R, Heller GV: Influence of race upon the prediction of cardiac events with stress Tc-99m Sestamibi tomographic imaging in patients with stable angina pectoris. American Journal of Cardiology 81 :293-297, 1998.
22. Stratmann HG, Mark AL, Amato ME, Wittry MD, Younis LT: Risk stratification using pre-hospital discharge exercise technetium-99m sestamibi myocardial tomography in men after acute myocardial infarction. American Heart Journal 136:87-93, 1998.
Nuclear Cardiology Publication Henry G. Stratmann, M.D.
23. Mandalapu BP, Amato ME, Stratmann HG: Technetium Tc 99m Sestamibi Myocardial Perfusion Imaging: Current Role for Evaluation of Prognosis. Chest 1 15:1684-1694, 1999.
6
24. Younis LT, Stratmann HG: Myocardial Perfusion Imaging in the Preoperative Evaluation of Vascular Patients. Chapter 30 in Cardiac Stress Testing and Imaging: A Clinician’s Guide (Ed. Marwick TH). Churchill Livingston Inc. 1996581 -596.
r
r s' -1
\
a 5 +)- r -.
5
u?
c 1, -
s7 C f u.